Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamune Conversion in Renal Allograft Recipients
NCT00273871Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of sirolimus in kidney transplant rejection, sponsored by Pfizer. Started Jan 2002; status: completed.
02
Drugs
sirolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00273871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273871.